Picard Medical (PMI) Debt to Equity (2025 - 2026)

Picard Medical (PMI) reported Debt to Equity of -$1.49 for Q1 2026, down 203.6% quarter-over-quarter from $1.44 in Q4 2025.

Picard Medical (PMI) Debt to Equity (2025 - 2026) Analysis & Trends

Picard Medical has reported Debt to Equity for 2 years, with the latest figure at -$1.49 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity changed N/A year-over-year to -$1.49; the trailing twelve-month figure through Mar 2026 stood at -$1.49 (changed N/A YoY), and the FY2025 full-year result was $1.44, changed N/A from the prior year.
  • Debt to Equity for Q1 2026 stood at -$1.49, down from $1.44 in the prior quarter.
  • The five-year high for Debt to Equity was $1.44 in Q4 2025, with the low at -$1.49 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.65
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.64
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.57
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.71
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.95
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.27
10 Picard Medical 13.47 Mn 13.47 Mn 275,000.00 -1.49

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.49
Dec 31, 2025 1.44